

Investment Rating - The report maintains a "Buy" rating for both A-shares and H-shares of the company [1]. Core Insights - The company achieved significant year-on-year profit growth, with a net profit of 26.23 billion yuan, representing a 201.1% increase [4][8]. - The company maintained a stable dividend payout ratio of 30.1%, with an annual dividend of 2.53 yuan per share, up 197.6% year-on-year [4][8]. - The new business value (NBV) reached 6.25 billion yuan, a year-on-year increase of 106.8% [4][7]. Financial Performance - In 2024, the company's operating revenue was 132.56 billion yuan, up 85.3% year-on-year, while insurance service revenue slightly decreased by 0.5% to 47.81 billion yuan [4][10]. - The weighted average return on equity (ROE) was 25.9%, an increase of 17.9 percentage points year-on-year [4]. - The net investment yield was 3.2%, a slight decrease of 0.2 percentage points year-on-year, while the total investment yield increased by 4.0 percentage points to 5.8% [4][8]. Business Development - The company continues to strengthen its individual insurance channel, with a focus on high-performing agents, achieving a monthly average productivity of 0.81 million yuan per agent, up 41% year-on-year [5]. - The individual insurance channel's first-year premium for long-term insurance reached 13.72 billion yuan, a year-on-year increase of 17.2% [5]. - The company is actively transforming its silver insurance business, with a total new business decline of 4.6% to 42.59 billion yuan, but the decline is narrowing compared to previous quarters [6]. Valuation and Forecast - The report adjusts the company's net profit forecasts for 2025 and 2026 to 22 billion yuan and 27.5 billion yuan, respectively, and introduces a new forecast for 2027 at 30.6 billion yuan [9]. - The A/H share prices correspond to a price-to-earnings value (PEV) of 0.59 for A-shares and 0.31 for H-shares in 2025 [9][10].